ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference 9c4a7578ad
Drug names54First applicant · distinct drug namesAcceptance records89First applicant · distinct acceptance numbersUnder-review numbers4First applicant · current under-review listCo-applicant records52Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
89 acceptance records as first applicant, grouped into 54 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
No verified English name 1 records · Latest accepted 2026/11/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602716 | Generic | 2026/11/05 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Dihydroxyaluminum Aminoacetate, Heavy Magnesium Carbonate and Aspirin Tablets（Ⅱ） 1 records · Latest accepted 2026/07/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601714 | Generic | 2026/07/17 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/02/27
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600248 | New drug | 2026/02/27 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Perospirone Hydrochloride Tablets 2 records · Latest accepted 2025/07/25
Generic · 2
Colesevelam Hydrochloride Tablets 3 records · Latest accepted 2025/05/21
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501828 | Generic | 2025/05/21 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CYHL2300046 | Generic | 2023/04/10 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CYHS2101982 | Generic | 2021/11/09 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Bisoprolol Fumarate Tablets 4 records · Latest accepted 2025/05/08
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500931 | Supplement | 2025/05/08 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CYHB2500930 | Supplement | 2025/05/08 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CYHS2300376 | Generic | 2023/02/07 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CYHS2300375 | Generic | 2023/02/07 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Cariprazine hydrochloride Capsules 6 records · Latest accepted 2025/04/18
Generic · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501485 | Generic | 2025/04/18 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CYHS2501484 | Generic | 2025/04/18 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CYHL2200039 | Generic | 2022/04/24 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CYHL2200038 | Generic | 2022/04/24 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CYHL2200037 | Generic | 2022/04/24 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CYHL2200036 | Generic | 2022/04/24 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Buspirone Hydrochloride Tablets 2 records · Latest accepted 2025/03/25
Generic · 2
No verified English name 1 records · Latest accepted 2025/03/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500959 | Generic | 2025/03/08 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Dapagliflozin Tablets 2 records · Latest accepted 2025/02/26
Generic · 2
No verified English name 4 records · Latest accepted 2024/12/22
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2401428 | New drug | 2024/12/22 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CXHL2401427 | New drug | 2024/12/22 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CXHL2401426 | New drug | 2024/12/22 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CXHL2401425 | New drug | 2024/12/22 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Entacapone,Levodopa and Carbidopa Tablets（Ⅱ） 1 records · Latest accepted 2024/12/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404442 | Generic | 2024/12/21 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Clarithromycin Tablets 1 records · Latest accepted 2024/12/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450599 | Supplement | 2024/12/07 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Loratadine Tablets 1 records · Latest accepted 2024/12/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450592 | Supplement | 2024/12/05 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/11/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401928 | Supplement | 2024/11/20 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/11/08
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450559 | Supplement | 2024/11/08 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Voglibose Tablets 1 records · Latest accepted 2024/10/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450512 | Supplement | 2024/10/12 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/09/25
Generic · 2
Diclofenac Sodium Sustained Release Tablets 2 records · Latest accepted 2024/08/20
Generic · 2
No verified English name 2 records · Latest accepted 2024/08/06
Supplement · 1New drug · 1
No verified English name 1 records · Latest accepted 2024/07/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402389 | Generic | 2024/07/30 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Ticagrelor Tablets 2 records · Latest accepted 2024/07/23
Generic · 2
Diclofenac Sodium Enteric-coated Tablets 1 records · Latest accepted 2024/05/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401604 | Generic | 2024/05/29 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/01/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400208 | Generic | 2024/01/15 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 4 records · Latest accepted 2024/01/13
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400070 | New drug | 2024/01/13 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CXHL2400069 | New drug | 2024/01/13 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CXHL2400068 | New drug | 2024/01/13 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CXHL2400067 | New drug | 2024/01/13 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Haloperidol Tablets 1 records · Latest accepted 2024/01/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400177 | Generic | 2024/01/12 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 3 records · Latest accepted 2023/12/29
Supplement · 1Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302800 | Supplement | 2023/12/29 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CYHS2200898 | Generic | 2022/06/16 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CYHS2200897 | Generic | 2022/06/16 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Ciprofloxacin Hydrochloride Tablets 2 records · Latest accepted 2023/11/02
Supplement · 2
Acarbose Tablets 2 records · Latest accepted 2023/06/17
Generic · 2
Mosapride Citrate Tablets 1 records · Latest accepted 2023/05/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301407 | Generic | 2023/05/24 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Gliclazide Modified Release Tablets 1 records · Latest accepted 2023/04/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301097 | Generic | 2023/04/20 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/03/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300924 | Generic | 2023/03/29 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 2 records · Latest accepted 2023/03/10
Supplement · 2
IsosorbideMononitrate Tablets 1 records · Latest accepted 2023/02/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300462 | Generic | 2023/02/11 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Pramipexole Dihydrochloride Tablets 2 records · Latest accepted 2023/01/07
Supplement · 2
No verified English name 2 records · Latest accepted 2023/01/05
Supplement · 2
Indapamide Tablets 1 records · Latest accepted 2022/12/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2202053 | Generic | 2022/12/10 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Hydrotalcite Chewable Tablets 1 records · Latest accepted 2022/11/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201951 | Generic | 2022/11/11 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Metformin Hydrochloride Extended-release Tablets 1 records · Latest accepted 2022/10/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201825 | Generic | 2022/10/25 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Atorvastatin Calcium Tablets 2 records · Latest accepted 2022/10/15
Generic · 2
Aspirin Enteric-coated Tablets 1 records · Latest accepted 2022/09/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201654 | Generic | 2022/09/30 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Mecobalamin Tablets 1 records · Latest accepted 2022/09/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201586 | Generic | 2022/09/22 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Trimetazidine Dihydrochloride Tablets 1 records · Latest accepted 2022/09/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201527 | Generic | 2022/09/15 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Clopidogrel Hydrogen Sulphate Tablets 1 records · Latest accepted 2022/08/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201252 | Generic | 2022/08/08 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 3 records · Latest accepted 2022/07/02
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2200463 | New drug | 2022/07/02 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CXHL2200462 | New drug | 2022/07/02 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| CXHL2200461 | New drug | 2022/07/02 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/06/23
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2200264 | New drug | 2022/06/23 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/04/24
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2200018 | New drug | 2022/04/24 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Metformin Hydrochloride Tablets 1 records · Latest accepted 2022/03/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200510 | Generic | 2022/03/31 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Irbesartan Tablets 1 records · Latest accepted 2022/01/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200009 | Generic | 2022/01/10 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Metoprolol Tartrate Tablets 1 records · Latest accepted 2022/01/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200005 | Generic | 2022/01/05 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 2 records · Latest accepted 2021/11/30
Supplement · 2
No verified English name 2 records · Latest accepted 2021/08/23
Supplement · 2
Memantine Hydrochloride Sustained-release Capsules 1 records · Latest accepted 2021/06/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101440 | Supplement | 2021/06/28 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/06/17
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2101204 | New drug | 2021/06/17 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Changes in the last 90 days
1 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 1 application
- 2026/11/05Accepted
No verified English name
CYHS2602716
Fact date: 2026/11/05 · Site observation date: 2026/11/06
View source ↗
Under review
4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | CYHS2602716 | Generic | 2026/11/05 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Dihydroxyaluminum Aminoacetate, Heavy Magnesium Carbonate and Aspirin Tablets（Ⅱ） | CYHS2601714 | Generic | 2026/07/17 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Perospirone Hydrochloride Tablets | CYHS2502697 | Generic | 2025/07/25 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Perospirone Hydrochloride Tablets | CYHS2502696 | Generic | 2025/07/25 | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
Catalogue holder records
60 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Colesevelam Hydrochloride Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20266140 | 2026/09/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Buspirone Hydrochloride Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20265742 | 2026/08/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Buspirone Hydrochloride Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20265741 | 2026/08/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20265058 | 2026/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20265002 | 2026/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20265003 | 2026/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20265057 | 2026/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20264978 | 2026/06/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20263155 | 2026/01/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20263156 | 2026/01/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Voglibose Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20094209 | 2025/11/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Diclofenac Sodium Enteric-coated Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20255833 | 2025/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Diclofenac Sodium Sustained Release Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20255690 | 2025/10/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Diclofenac Sodium Sustained Release Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20255691 | 2025/10/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20090337 | 2025/09/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ticagrelor Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20255443 | 2025/09/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Clarithromycin Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20065652 | 2025/09/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20254425 | 2025/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Haloperidol Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20254337 | 2025/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mosapride Citrate Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20244986 | 2024/09/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20247204 | 2024/09/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ciprofloxacin Hydrochloride Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H33020388 | 2024/08/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ciprofloxacin Hydrochloride Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20054866 | 2024/08/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Acarbose Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20244564 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Acarbose Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20244563 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| IsosorbideMononitrate Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20244385 | 2024/07/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Hydrotalcite Chewable Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20244127 | 2024/06/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20244074 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gliclazide Modified Release Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20243959 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bisoprolol Fumarate Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20243947 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bisoprolol Fumarate Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20243946 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mecobalamin Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20243796 | 2024/05/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metformin Hydrochloride Extended-release Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20243541 | 2024/04/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trimetazidine Dihydrochloride Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20243473 | 2024/04/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Indapamide Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20243399 | 2024/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Atorvastatin Calcium Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20243097 | 2024/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Atorvastatin Calcium Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20243098 | 2024/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Aspirin Enteric-coated Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20243064 | 2024/01/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Clopidogrel Hydrogen Sulphate Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20234617 | 2023/12/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20237159 | 2023/11/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20234524 | 2023/11/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20237159 | 2023/11/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metformin Hydrochloride Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20234052 | 2023/08/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metoprolol Tartrate Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20233876 | 2023/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Irbesartan Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20233681 | 2023/06/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20183125 | 2023/03/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20183124 | 2023/03/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20193125 | 2022/09/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Memantine Hydrochloride Sustained-release Capsules | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20217137 | 2021/12/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20130114 | 2021/07/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Memantine Hydrochloride Sustained-release Capsules | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20213467 | 2021/06/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levofloxacin Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20213218 | 2021/03/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pramipexole Dihydrochloride Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20183367 | 2020/09/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pramipexole Dihydrochloride Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20183368 | 2020/09/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pramipexole Dihydrochloride Prolonged-release Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20203342 | 2020/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pramipexole Dihydrochloride Prolonged-release Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20203341 | 2020/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20130115 | 2020/07/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levetiracetam Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20143178 | 2020/03/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levetiracetam Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20184031 | 2020/03/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Simvastatin Tablets | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20000009 | 2019/08/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
3 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | Y20200000434 | I | 2022/09/15 | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | Y20190001253 | A | — | CDE ↗ |
| No verified English name | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | Y20190001216 | A | 2024/10/12 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
52 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Metformin Hydrochloride Extended-release Tablets | CYHS2602344 | Generic | 2026/09/20 | Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Etoricoxib Tablets | CYHB2601038 | Supplement | 2026/06/01 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Ezetimibe and Simvastatin Tablets | CYHB2600811 | Supplement | 2026/04/23 | Hu Zhou Ya Se Pharmaceutical Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| No verified English name | CYHS2600212 | Generic | 2026/01/20 | Ran Dian (Nanjing) Biopharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Finerenone Tablets | CYHS2503333 | Generic | 2025/09/09 | Jiangxi Tai Ji Li Biopharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Finerenone Tablets | CYHS2503332 | Generic | 2025/09/09 | Jiangxi Tai Ji Li Biopharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| No verified English name | CYHB2501498 | Supplement | 2025/07/30 | Suzhou Di Yi Pharmaceutical Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Acyclovir Tablets | CYHS2502385 | Generic | 2025/07/05 | Zhejiang Che Tou Pharmaceutical Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Acyclovir Tablets | CYHS2502384 | Generic | 2025/07/05 | Zhejiang Che Tou Pharmaceutical Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Acyclovir Tablets | CYHS2502383 | Generic | 2025/07/05 | Zhejiang Che Tou Pharmaceutical Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Brivaracetam Tablets | CYHS2501808 | Generic | 2025/05/17 | Zhejiang He Ze Pharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Brivaracetam Tablets | CYHS2501807 | Generic | 2025/05/17 | Zhejiang He Ze Pharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Metoprolol Succinate Extended-release Capsules | CYHB2500779 | Supplement | 2025/04/19 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Ezetimibe and Simvastatin Tablets | CYHS2500922 | Generic | 2025/03/05 | Zhejiang Ya Se Pharmaceuticals Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| No verified English name | CYHS2500848 | Generic | 2025/02/26 | Ran Dian (Nanjing) Biopharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Mosapride Citrate Tablets | CYHS2500695 | Generic | 2025/02/11 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| No verified English name | CYHS2500567 | Generic | 2025/02/06 | Suzhou Hua Jian Rui Da Pharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Fluvastatin Sodium Extended Release Tablets | CYHS2500464 | Generic | 2025/01/24 | Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| No verified English name | CYHS2404421 | Generic | 2024/12/20 | Suzhou Hua Jian Rui Da Pharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Paroxetine Hydrochloride Tablets | CYHS2403581 | Generic | 2024/10/23 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Mesalazine Enteric-coated Tablets | CYHS2402885 | Generic | 2024/09/03 | Zhejiang Mei Di Shen Biopharmaceuticals Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Etoricoxib Tablets | CYHB2401212 | Supplement | 2024/08/06 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Vonoprazan Fumarate Tablets | CYHS2402077 | Generic | 2024/07/09 | Hangzhou Huang Sen Bio Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Vonoprazan Fumarate Tablets | CYHS2401466 | Generic | 2024/05/15 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Empagliflozin Tablets | CYHS2401379 | Generic | 2024/05/09 | Zhejiang Hong Yuan Pharma Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Doxofylline Tablets | CYHS2401241 | Generic | 2024/04/25 | Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Doxofylline Tablets | CYHS2401240 | Generic | 2024/04/25 | Hangzhou Mu Yuan Biopharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Beraprost Sodium Tablets | CYHS2401009 | Generic | 2024/04/04 | Zhejiang Mei Di Shen Biopharmaceuticals Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Glucosamine Sulfate Capsules | CYHS2400911 | Generic | 2024/03/26 | Guangdong Jiang Zheng Pharma Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Levofloxacin Tablets | CYHS2400722 | Generic | 2024/02/29 | Guangdong Sha Xi Pharmaceutical Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Sevelamer Carbonate Powder for oral suspension | CYHB2400221 | Supplement | 2024/02/06 | Hangzhou An Yuan Biopharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Sevelamer Carbonate Powder for oral suspension | CYHB2400220 | Supplement | 2024/02/06 | Hangzhou An Yuan Biopharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Valganciclovir Hydrochloride Tablets | CYHS2400441 | Generic | 2024/02/02 | Zhejiang Che Tou Pharmaceutical Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| No verified English name | CYHS2400407 | Generic | 2024/01/31 | Shenzhen Shi Lang Bo Biopharmaceuticals Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| No verified English name | CYHS2400078 | Generic | 2024/01/06 | Name not romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Mesalazine Enteric-coated Tablets | CYHS2303657 | Generic | 2023/12/28 | Hangzhou Huang Sen Bio Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Ursodeoxycholic Acid Capsules | CYHS2303153 | Generic | 2023/11/17 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Compound Glycyrrhizin Tablets | CYHS2303019 | Generic | 2023/11/07 | Zhejiang Mei Di Shen Biopharmaceuticals Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Rivaroxaban Tablets | CYHS2302260 | Generic | 2023/08/24 | Jiangxi Tong He Pharma Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Rivaroxaban Tablets | CYHS2302259 | Generic | 2023/08/24 | Jiangxi Tong He Pharma Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Rivaroxaban Tablets | CYHS2302258 | Generic | 2023/08/24 | Jiangxi Tong He Pharma Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Choline Fenofibrate Sustained-release Capsules | CYHS2301502 | Generic | 2023/06/02 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Choline Fenofibrate Sustained-release Capsules | CYHS2301501 | Generic | 2023/06/02 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Metoprolol Succinate Extended-release Capsules | CYHS2300677 | Generic | 2023/03/03 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Sevelamer Carbonate Powder for oral suspension | CYHS2201313 | Generic | 2022/08/16 | Hangzhou An Yuan Biopharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Sevelamer Carbonate Powder for oral suspension | CYHS2201312 | Generic | 2022/08/16 | Hangzhou An Yuan Biopharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Nicergoline Tablets | CYHS2200980 | Generic | 2022/06/30 | Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Sildenafil Citrate Oral Disintegrating Tablets | CYHS2200598 | Generic | 2022/04/15 | Jing Shi (Hangzhou) Pharma Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Etoricoxib Tablets | CYHS2200303 | Generic | 2022/02/11 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Etoricoxib Tablets | CYHS2200302 | Generic | 2022/02/11 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Pregabalin Capsules | CYHS2101314 | Generic | 2021/06/22 | Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
| Pregabalin Capsules | CYHS2101313 | Generic | 2021/06/22 | Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.